和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02142 和铂医药-B

未开盘 03-05 16:08:25

11.680

+0.220

+1.92%

最高12.180	最低11.550	成交量204.70万
今开11.660	昨收11.460	日振幅5.50%
总市值101.62亿	流通市值101.62亿	总股本8.70亿
成交额2,425万	换手率0.24%	流通股本8.70亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"和铂医药-B","latestPrice":11.68,"timestamp":1772698105004,"preClose":11.46,"halted":0,"volume":2047000,"delay":0,"changeRate":0.01919720767888297,"floatShares":869999999,"shares":869999999,"eps":0.003616,"marketStatus":"未开盘","change":0.22,"latestTime":"03-05 16:08:25","open":11.66,"high":12.18,"low":11.55,"amount":24249010,"amplitude":0.054974,"askPrice":11.78,"askSize":2000,"bidPrice":11.67,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":0.661,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772760600000},"marketStatusCode":0,"adr":0,"listingDate":1607529600000,"exchange":"SEHK","adjPreClose":11.46,"openAndCloseTimeList":[[1772674200000,1772683200000],[1772686800000,1772697600000]],"volumeRatio":0.818701,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142","defaultTab":"news","newsList":[{"id":"1112026828","title":"和铂医药-B（02142）2月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1112026828","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112026828?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:51","pubTimestamp":1772700662,"startTime":"0","endTime":"0","summary":"和铂医药控股有限公司于2026年3月5日公布截至2026年2月28日的股份变动月报表。公告显示，公司本月股本总体保持稳定，未有新的发行、转让或注销活动。公司截至2月末的法定股本数量为20,000,000,000股，面值每股USD 0.000025，注册股本合计USD 500,000。报告期内已发行股份为869,591,522股，库存股份为25,937,000股，与上月保持一致。综上，截至2月28日，公司已发行股份及注册股本均无实质变动，整体股本结构保持稳定。公告由执行董事王劲松签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142"],"gpt_icon":0},{"id":"2616553371","title":"每日卖空追踪 | 和铂医药-B 03月03日卖空量成交10.8万股，卖空比例为4.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616553371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616553371?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526629,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间03月03日，跌3.14%，卖空量成交10.8万股，较上一交易日减少72.16%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163341a445cb7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163341a445cb7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2616568371","title":"“爆单”出海 中国创新药开年出海总额超530亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616568371","media":"中国商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616568371?lang=zh_cn&edition=full","pubTime":"2026-03-03 15:41","pubTimestamp":1772523676,"startTime":"0","endTime":"0","summary":"2026年开年，中国药企出海节奏密集，截至2月25日，年内中国创新药已发生44起对外授权交易事件，首付款约为31.23亿美元，总金额达532.76亿美元。一季度未过，创新药出海交易总额已超过2025年全年总额的1/3。根据协议，荣昌生物将获得6.5亿美元首付款，并有资格获得最高达49.5亿美元的里程碑付款，交易总额高达56亿美元。到了2月25日，这一数字已攀升至532.76亿美元。小核酸药物正成为出海的新引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303155542a69c7e68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303155542a69c7e68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","BK1583","02142","BK1574","BK1161","06978"],"gpt_icon":0},{"id":"2614009604","title":"中泰证券：维持和铂医药-B(02142)“买入”评级 仅重链抗体HBM4003出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009604","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009604?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:29","pubTimestamp":1772155785,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中泰证券发布研报称，维持和铂医药-B“买入”评级。中泰证券主要观点如下：事件2026年2月23日，和铂医药宣布与Solstice Oncology达成授权协议及股权合作，授予对方一款临床阶段候选产品HBM4003在大中华区以外地区的独家开发及商业化权益。HBM4003在I期单药研究试验中显示了其良好的安全性和强大的疗效潜在适应症包括黑色素瘤、非小细胞肺癌、肝细胞癌、神经内分泌瘤等多种晚期实体肿瘤。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407956.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600918","02142"],"gpt_icon":0},{"id":"2613732656","title":"每日卖空追踪 | 和铂医药-B 02月23日卖空量成交27.8万股，卖空比例为4.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613732656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613732656?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835427,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间02月23日，涨4.41%，卖空量成交27.8万股，较上一交易日增加8.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163326a4be7d3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163326a4be7d3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2613927026","title":"港股异动 | 和铂医药-B(02142)早盘涨超8% 新一代CTLA-4抗体出海 总额或超12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613927026","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613927026?lang=zh_cn&edition=full","pubTime":"2026-02-23 09:46","pubTimestamp":1771811192,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和铂医药-B(02142)早盘涨超8%，截至发稿，涨7.92%，报13.21港元，成交额2179.47万港元。消息面上，2月23日，和铂医药宣布将新一代CTLA-4抗体HBM4003大中华区外全球权益授权Solstice Oncology，后者支付逾1.05亿美元前期对价，包括5000万美元首付款，500万美元近期付款以及价值逾5000万美元的公司股权。此外，和铂医药还将获得最高11亿美元的里程碑付款，以及分级销售分成。公开资料显示，Solstice Oncology为一家多个头部风险投资机构联合创立的临床阶段生物技术公司，此次合作为NewCo模式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","02142","BK1574","VT","BK1583","BK1161","VXUS"],"gpt_icon":0},{"id":"2613325057","title":"和铂医药-B盘中异动 早盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613325057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613325057?lang=zh_cn&edition=full","pubTime":"2026-02-23 09:31","pubTimestamp":1771810275,"startTime":"0","endTime":"0","summary":"2026年02月23日早盘09时31分，和铂医药-B股票出现异动，股价快速拉升5.39%。截至发稿，该股报12.900港元/股，成交量26万股，换手率0.03%，振幅2.94%。和铂医药-B股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，和铂医药-B、云康集团、药明生物涨幅较大，振幅较大的相关个股有康宁杰瑞制药-B、云康集团、复宏汉霖，振幅分别为4.67%、4.29%、2.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602230931159541a2bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602230931159541a2bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1583","02142"],"gpt_icon":0},{"id":"2613927206","title":"和铂医药-B(02142)与Solstice Oncology就HBM4003订立独家授权协议及股权合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2613927206","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613927206?lang=zh_cn&edition=full","pubTime":"2026-02-23 08:10","pubTimestamp":1771805456,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B 发布公告，公司已与Solstice Oncology订立独家授权协议及股权合作协议，据此，公司同意向Solstice Oncology授予独家授权，以在大中华区以外地区开发及商业化其临床阶段组合资产HBM4003。根据该等协议的条款，公司有资格获得价值超过1.05亿美元的前期对价，包括：5000万美元的首付款，500万美元的近期付款，及向公司发行及配发于Solstice Oncology的超过5000万美元的股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和铂医药-B(02142)与Solstice Oncology就HBM4003订立独家授权协议及股权合作协议","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1161","BK1574","BK1583"],"gpt_icon":1},{"id":"1156392830","title":"和铂医药-B有望获得总额高达11亿美元的额外开发、监管及商业里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1156392830","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156392830?lang=zh_cn&edition=full","pubTime":"2026-02-23 08:04","pubTimestamp":1771805055,"startTime":"0","endTime":"0","summary":"和铂医药-B（HBM HOLDINGS-B）宣布，公司符合资格获得总额最高达11亿美元的额外开发、监管及商业里程碑付款。\n这一重大财务前景基于公司现有合作协议的条款，反映出其研发管线与商业合作的强劲潜力。\n里程碑付款将分阶段兑现，具体与候选药物的临床进展、监管审批以及最终商业化成果紧密挂钩。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2612439877","title":"每日卖空追踪 | 和铂医药-B 02月16日卖空量成交11.3万股，卖空比例为11.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612439877","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612439877?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230624,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间02月16日，涨1.11%，卖空量成交11.3万股，较上一交易日减少70.57%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163312a700dee0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163312a700dee0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02142","BK1583"],"gpt_icon":0},{"id":"2611624541","title":"每日卖空追踪 | 和铂医药-B 02月13日卖空量成交11.6万股，卖空比例为8.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611624541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611624541?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971429,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间02月13日，跌0.85%，卖空量成交11.6万股，较上一交易日减少65.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163357a49ff951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163357a49ff951&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02142","BK1583"],"gpt_icon":0},{"id":"2610348945","title":"和铂医药-B02月12日主力净流入110.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610348945","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610348945?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:15","pubTimestamp":1770884154,"startTime":"0","endTime":"0","summary":"02月12日, 和铂医药-B股价涨0.60%，报收11.79元，成交金额1499.6万元，换手率0.15%，振幅3.84%，量比0.54。和铂医药-B今日主力资金净流入110.5万元，上一交易日主力净流出0万元。该股近5个交易日上涨6.21%，主力资金累计净流出219.0万元；近20日主力资金累计净流出216.0万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212162104a49b9076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212162104a49b9076&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02142","BK1583","BK1161"],"gpt_icon":0},{"id":"2610674955","title":"每日卖空追踪 | 和铂医药-B 02月11日卖空量成交12.3万股，卖空比例为5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610674955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610674955?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:30","pubTimestamp":1770798630,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间02月11日，涨0.09%，卖空量成交12.3万股，较上一交易日减少70.64%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163358a49730b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163358a49730b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2610948306","title":"和铂医药-B盘中异动 早盘股价大涨5.21%报11.910港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610948306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610948306?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:38","pubTimestamp":1770691135,"startTime":"0","endTime":"0","summary":"2026年02月10日早盘10时38分，和铂医药-B股票出现异动，股价急速上涨5.21%。截至发稿，该股报11.910港元/股，成交量93.2万股，换手率0.11%，振幅6.36%。资金方面，该股资金流入630.242万港元，流出216.086万港元。和铂医药-B股票所在的生物技术行业中，整体涨幅为2.81%。其相关个股中，宜明昂科-B、荣昌生物、再鼎医药涨幅较大，振幅较大的相关个股有帝王国际投资、泰格医药、旺山旺水-B，振幅分别为10.91%、7.71%、7.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010385597a5905e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010385597a5905e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","02142","BK1574"],"gpt_icon":0},{"id":"2610053663","title":"每日卖空追踪 | 和铂医药-B 02月09日卖空量成交8.7万股，卖空比例为5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610053663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610053663?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625828,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间02月09日，涨2.63%，卖空量成交8.7万股，较上一交易日减少75.21%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163801a48e5c2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163801a48e5c2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","02142"],"gpt_icon":0},{"id":"2609515606","title":"每日卖空追踪 | 和铂医药-B 02月06日卖空量成交20.7万股，卖空比例为8.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609515606","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609515606?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366629,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间02月06日，跌0.81%，卖空量成交20.7万股，较上一交易日减少41.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163425a483ced7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163425a483ced7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02142","BK1583"],"gpt_icon":0},{"id":"2609515985","title":"和铂医药-B02月06日主力净流出78.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2609515985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609515985?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:15","pubTimestamp":1770365757,"startTime":"0","endTime":"0","summary":"02月06日, 和铂医药-B股价跌0.81%，报收11.03元，成交金额2639.6万元，换手率0.28%，振幅6.56%，量比0.74。和铂医药-B今日主力资金净流出78.7万元，上一交易日主力净流入1.6万元。该股近5个交易日下跌6.89%，主力资金累计净流出100.3万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1599.5万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206162137a6dab27b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206162137a6dab27b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1583","02142"],"gpt_icon":0},{"id":"1183875973","title":"和铂医药控股（02142）更新1月股份变动月报，股本微增","url":"https://stock-news.laohu8.com/highlight/detail?id=1183875973","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183875973?lang=zh_cn&edition=full","pubTime":"2026-02-06 08:06","pubTimestamp":1770336382,"startTime":"0","endTime":"0","summary":"和铂医药控股有限公司于2026年2月6日披露截至2026年1月31日的股份变动月报表。报告期内，法定股本维持20,000,000,000股，面值USD0.000025，注册总额USD500,000。截至1月底，公司已发行普通股从上月底的868,681,522股增至869,591,522股，库藏股从25,437,000股增至25,937,000股，总股本达到895,528,522股。报告期内公司因首次公开发售后购股权计划行使新增1,410,000股，同时回购500,000股并转为库存，使当月净增已发行股份910,000股。公告由执行董事王劲松签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142"],"gpt_icon":0},{"id":"2608877003","title":"港股异动 | 和铂医药-B(02142)盈喜后高开逾3% 预期年度溢利至多约9500万美元 公司经常性收入持续增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2608877003","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608877003?lang=zh_cn&edition=full","pubTime":"2026-02-04 09:23","pubTimestamp":1770168199,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和铂医药-B盈喜后高开逾3%，截至发稿，涨3.44%，报11.44港元，成交额48.05万港元。消息面上，2月4日，和铂医药-B发布公告，预期截至2025年12月31日止年度的溢利介乎约8800万美元至约9500万美元，而截至2024年12月31日止年度则为溢利约270万美元。预期经调整溢利总额介乎9100万美元至9800万美元。公告称，公司预期溢利增加主要归因于：公司的经常性收入的持续增长，例如与阿斯利康及百时美施贵宝开展基于平台的研究合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1574","BK4585","VT","BK1583","VXUS","02142","BK1161"],"gpt_icon":0},{"id":"2608384676","title":"和铂医药-B(02142.HK)：预期2025年经调整溢利总额9100万至9800万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608384676","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608384676?lang=zh_cn&edition=full","pubTime":"2026-02-04 08:17","pubTimestamp":1770164221,"startTime":"0","endTime":"0","summary":"格隆汇2月4日丨和铂医药-B发布公告，预期截至2025年12月31日止年度的溢利介乎约8800万美元至约9500万美元，而截至2024年12月31日止年度则为溢利约270万美元。预期经调整溢利总额介乎9100万美元至9800万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260204/31996719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02142","BK1161","BK1574","BK1583"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":0.0561},{"period":"3month","weight":-0.1775},{"period":"6month","weight":-0.3182},{"period":"1year","weight":0.9532},{"period":"ytd","weight":-0.0395}],"compareEarnings":[{"period":"1week","weight":-0.0402},{"period":"1month","weight":-0.0564},{"period":"3month","weight":-0.0293},{"period":"6month","weight":-0.0038},{"period":"1year","weight":0.0732},{"period":"ytd","weight":-0.0121}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品主要包括巴托利单抗（HBM9161）、HBM9378、HBM7020、TCE Program、普鲁苏拜单抗（HBM4003）以及HBM7022等。该公司产品主要用于治疗全身型重症肌无力（gMG）、慢性阻塞性肺病（COPD）、哮喘、自身免疫疾病、黑色素瘤、结直肠癌以及实体瘤等。该公司通过专有抗体技术平台“Harbour Mice”、“HBICE”、“HBICA”及单克隆B细胞筛选平台提供下一代抗体以及生物解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.083377},{"month":2,"riseRate":0.333333,"avgChangeRate":0.000026},{"month":3,"riseRate":0.333333,"avgChangeRate":0.03208},{"month":4,"riseRate":0.4,"avgChangeRate":0.013317},{"month":5,"riseRate":0.6,"avgChangeRate":0.040454},{"month":6,"riseRate":0.2,"avgChangeRate":-0.066065},{"month":7,"riseRate":0.4,"avgChangeRate":0.030357},{"month":8,"riseRate":0.2,"avgChangeRate":0.005624},{"month":9,"riseRate":0.4,"avgChangeRate":-0.065735},{"month":10,"riseRate":0,"avgChangeRate":-0.180686},{"month":11,"riseRate":0.8,"avgChangeRate":0.25789},{"month":12,"riseRate":0.6,"avgChangeRate":0.266929}],"exchange":"SEHK","name":"和铂医药-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和铂医药-B,02142,和铂医药-B股票,和铂医药-B股票老虎,和铂医药-B股票老虎国际,和铂医药-B行情,和铂医药-B股票行情,和铂医药-B股价,和铂医药-B股市,和铂医药-B股票价格,和铂医药-B股票交易,和铂医药-B股票购买,和铂医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}